Equity Details
Price & Market Data
Price: $1.15
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $8,188,759
Daily Volume: 0
Performance Metrics
1 Week: 33.14%
1 Month: 14.50%
3 Months: 9.83%
6 Months: 59.03%
1 Year: -38.44%
YTD: 54.21%
About Curative Biotechnology, Inc. (CUBT)
Understand Curative Biotechnology, Inc. (CUBT)'s current market standing. Current price: 1.15, daily change: $0.00 / 0.00%. Market cap: 8,188,759. Detailed performance for all periods.
Company Details
Employees: 3
Sector: Distribution services
Industry: Electronics distributors
Country: United States
Details
Curative Biotechnology, Inc., a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular degeneration and geographic atrophy; IMT504, a novel immunotherapy to treat late-stage rabies; and CUBT906, a fully humanized CD56 monoclonal antibody carrying a cytotoxic drug conjugate directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504 to treat late-stage rabies and COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.